CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic Screening for Atrial Fibrillation With ECG: USPSTF Recommendation Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD Long-term Survival following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-On Study) Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial Correction of a pathogenic gene mutation in human embryos
|<< 1 2 3 4 5 6 7 ...>>|

GuidelineOctober 2017, Volume 10, Issue 10

JOURNAL：Circ Cardiovasc Qual Outcomes. Article Link

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Jneid H, Addison D, Bhatt DL et al. Keywords: AHA Scientific Statements; ST-elevation myocardial infarction; acute myocardial infarction; non–ST-elevation myocardial infarction; performance measures; quality indicators; quality measures

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top